Cargando…

Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands

Adjuvant combinations may enhance or broaden the expression of immune responses to vaccine antigens. Information on whether established Alum type adjuvants can be combined with experimental CD1d ligand adjuvants is currently lacking. In this study, we used a murine Clostridioides difficile immunizat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Gillian A., Norman, Kaylee, Amadou Amani, Souwelimatou, Shadid, Tyler M., Ballard, Jimmy D., Lang, Mark L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794951/
https://www.ncbi.nlm.nih.gov/pubmed/35095921
http://dx.doi.org/10.3389/fimmu.2021.818734
_version_ 1784640939460919296
author Lang, Gillian A.
Norman, Kaylee
Amadou Amani, Souwelimatou
Shadid, Tyler M.
Ballard, Jimmy D.
Lang, Mark L.
author_facet Lang, Gillian A.
Norman, Kaylee
Amadou Amani, Souwelimatou
Shadid, Tyler M.
Ballard, Jimmy D.
Lang, Mark L.
author_sort Lang, Gillian A.
collection PubMed
description Adjuvant combinations may enhance or broaden the expression of immune responses to vaccine antigens. Information on whether established Alum type adjuvants can be combined with experimental CD1d ligand adjuvants is currently lacking. In this study, we used a murine Clostridioides difficile immunization and challenge model to evaluate Alum (Alhydrogel™), α-galactosylceramide (α-GC), and one of its analogs 7DW8-5 singly and in combination as vaccine adjuvants. We observed that the Alum/α-GC combination caused modest enhancement of vaccine antigen-specific IgG1 and IgG2b responses, and a broadening to include IgG2c that did not significantly impact overall protection. Similar observations were made using the Alum/7DW8-5 combination. Examination of the impact of adjuvants on NKT cells revealed expansion of invariant NKT (iNKT) cells with modest expansion of their iNKTfh subset and little effect on diverse NKT (dNKT) cells. Side effects of the adjuvants was determined and revealed transient hepatotoxicity when Alum/α-GC was used in combination but not singly. In summary these results showed that the Alum/α-GC or the Alum/7DW8-5 combination could exert distinct effects on the NKT cell compartment and on isotype switch to produce Th1-driven IgG subclasses in addition to Alum/Th2-driven subclasses. While Alum alone was efficacious in stimulating IgG-mediated protection, and α-GC offered no apparent additional benefit in the C. difficile challenge model, the work herein reveals immune response features that could be optimized and harnessed in other vaccine contexts.
format Online
Article
Text
id pubmed-8794951
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87949512022-01-29 Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands Lang, Gillian A. Norman, Kaylee Amadou Amani, Souwelimatou Shadid, Tyler M. Ballard, Jimmy D. Lang, Mark L. Front Immunol Immunology Adjuvant combinations may enhance or broaden the expression of immune responses to vaccine antigens. Information on whether established Alum type adjuvants can be combined with experimental CD1d ligand adjuvants is currently lacking. In this study, we used a murine Clostridioides difficile immunization and challenge model to evaluate Alum (Alhydrogel™), α-galactosylceramide (α-GC), and one of its analogs 7DW8-5 singly and in combination as vaccine adjuvants. We observed that the Alum/α-GC combination caused modest enhancement of vaccine antigen-specific IgG1 and IgG2b responses, and a broadening to include IgG2c that did not significantly impact overall protection. Similar observations were made using the Alum/7DW8-5 combination. Examination of the impact of adjuvants on NKT cells revealed expansion of invariant NKT (iNKT) cells with modest expansion of their iNKTfh subset and little effect on diverse NKT (dNKT) cells. Side effects of the adjuvants was determined and revealed transient hepatotoxicity when Alum/α-GC was used in combination but not singly. In summary these results showed that the Alum/α-GC or the Alum/7DW8-5 combination could exert distinct effects on the NKT cell compartment and on isotype switch to produce Th1-driven IgG subclasses in addition to Alum/Th2-driven subclasses. While Alum alone was efficacious in stimulating IgG-mediated protection, and α-GC offered no apparent additional benefit in the C. difficile challenge model, the work herein reveals immune response features that could be optimized and harnessed in other vaccine contexts. Frontiers Media S.A. 2022-01-14 /pmc/articles/PMC8794951/ /pubmed/35095921 http://dx.doi.org/10.3389/fimmu.2021.818734 Text en Copyright © 2022 Lang, Norman, Amadou Amani, Shadid, Ballard and Lang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Lang, Gillian A.
Norman, Kaylee
Amadou Amani, Souwelimatou
Shadid, Tyler M.
Ballard, Jimmy D.
Lang, Mark L.
Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands
title Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands
title_full Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands
title_fullStr Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands
title_full_unstemmed Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands
title_short Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands
title_sort use of a clostridioides difficile murine immunization and challenge model to evaluate single and combination vaccine adjuvants consisting of alum and nkt cell-activating ligands
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794951/
https://www.ncbi.nlm.nih.gov/pubmed/35095921
http://dx.doi.org/10.3389/fimmu.2021.818734
work_keys_str_mv AT langgilliana useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands
AT normankaylee useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands
AT amadouamanisouwelimatou useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands
AT shadidtylerm useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands
AT ballardjimmyd useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands
AT langmarkl useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands